UW Health is a part of the clinical trial for the drug. UW Health’s principal investigator for the Regeneron trial, Dr. William Hartman, said this authorization is a big step.
Office of Strategic Communication
UW Health is a part of the clinical trial for the drug. UW Health’s principal investigator for the Regeneron trial, Dr. William Hartman, said this authorization is a big step.